$5.88
0.264.72%
Last update: Dec 18, 11:14 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CEL-SCI (CVM) stock?
You can purchase shares of CEL-SCI (AMEX:CVM) through any online brokerage.
Who are CEL-SCI (CVM) competitors?
Other companies in CEL-SCI’s space includes: Galecto Inc (NASDAQ:GLTO), Kezar Life Sciences Inc (NASDAQ:KZR), Skye Bioscience Inc (NASDAQ:SKYE), FibroGen Inc (NASDAQ:FGEN) and Palatin Technologies Inc (AMEX:PTN).
What is the forecast, or price target, for CEL-SCI (CVM) stock?
CEL-SCI has a consensus price target of $13.00.
What is the current price for CEL-SCI (CVM)?
The stock price for CEL-SCI (AMEX: CVM) is $5.875 last updated December 18, 2025 at 11:14 AM EST.
Does CEL-SCI (CVM) pay a dividend?
There are no upcoming dividends for CEL-SCI.
When is CEL-SCI (AMEX:CVM) reporting earnings?
CEL-SCI does not have any upcoming earnings scheduled.
Is CEL-SCI (CVM) going to split?
There is no upcoming split for CEL-SCI.
What sector and industry does CEL-SCI (CVM) operate in?
CEL-SCI is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
